PRELUDE CAPITAL MANAGEMENT, LLC Biohaven Pharmaceutical Holding Company Ltd. Transaction History

PRELUDE CAPITAL MANAGEMENT, LLC portfolio value:

$5.37M
portfolio value

PRELUDE CAPITAL MANAGEMENT, LLC quarter portfolio value change:

+3.75%
quarter

Biohaven Pharmaceutical Holding Company Ltd. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -30.79% -15.81K shares -2.11M $151.17 35.54K
Q2 2022 share Increase 0.00% 51.36K shares 7.48M $145.71 51.36K
Q3 2020 share Decrease -100.00% -2.12K shares -156K $65.01 0
Q2 2020 share Increase 0.00% 2.12K shares 156K $73.11 2.12K
Q1 2020 share Decrease -100.00% -4.58K shares -249K $34.03 0
Q4 2019 call Decrease -100.00% -100 shares -4K $54.44 0
Q4 2019 put Decrease -100.00% -100 shares -4K $54.44 0
Q4 2019 share Increase +303.97% 3.44K shares 202K $54.44 4.58K
Q3 2019 call Decrease -96.55% -2.8K shares -123K $41.72 100
Q3 2019 share Decrease -93.28% -15.73K shares -692K $41.72 1.13K
Q3 2019 put Increase 0.00% 100 shares 4K $41.72 100
Q2 2019 share Increase +96.08% 8.26K shares 296K $43.79 16.86K
Q2 2019 call Increase 0.00% 2.9K shares 127K $43.79 2.9K
Q1 2019 share Increase 0.00% 8.60K shares 443K $51.47 8.60K
Q4 2018 share Decrease -100.00% -211 shares -8K $36.98 0
Q3 2018 share Increase 0.00% 211 shares 8K $37.55 211
Q2 2018 call Decrease -100.00% -39.7K shares -1.02M $39.52 0
Q1 2018 call Increase 0.00% 39.7K shares 1.02M $25.76 39.7K